Okla. Admin. Code § 310:638-1-7 - Cutoff levels for drug confirmation testing in urine
(a) All specimens identified as positive on the initial test shall be confirmed using gas chromatography/mass spectrometry (GC/MS), or an equivalent accepted method of equal or greater accuracy as approved by the Commissioner of Health, at the following cutoff levels for these drugs or their metabolites. All confirmations shall be by quantitative analysis. Concentrations which exceed the linear region of the standard curve shall be documented in the testing facility record as "greater than the highest standard curve value."
(1) marijuana metabolites: 15 ng/ml (Delta-9-tetrahydrocannabinol-9-carboxylic acid)
(2) cocaine metabolites: 150 ng/ml (Benzoylecgonine)
(3) opiates and metabolites: 2000 ng/ml; opiates and metabolites include the following:
(A) codeine;
(B) morphine;
(C) heroin (10 ng/ml for tests for 6-Acetylmorphine when the morphine concentration exceeds 2000 ng/mL);
(4) semi-synthetic and synthetic narcotics: 300 ng/ml
(A) hydrocodone;
(B) hydromorphone;
(C) meperidine; (confirmatory test level of 500 ng/ml shall be used for meperidine)
(D) methadone;
(E) oxycodone;
(F) propoxyphene;
(5) phencyclidine: 25 ng/ml
(6) amphetamines: 500 ng/ml; amphetamines include the following:
(A) amphetamines;
(B) methamphetamines; (Specimen must also contain amphetamine at a concentration of greater than 200 ng/mL)
(C) methylenedioxyamphetamine;
(D) methylenedioxymethamphetamine;
(E) phentermine.
(7) barbiturates: 300 ng/ml; barbiturates include the following:
(A) amobarbital;
(B) butalbital;
(C) pentobarbital;
(D) secobarbital;
(8) benzodiazepines: 300 ng/ml; benzodiazepines include the following:
(A) diazepam;
(B) chlordiazepoxide;
(C) alprazolam;
(D) clorazepate; and
(9) methaqualone: 300 ng/ml.
(b) These test levels are subject to change by the Department as advances in technology or other considerations warrant identification of these 'substances at other concentration.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.